 |
|
|
 |
001
|
Athletics
and Heavy resistance.
|
|
002
|
Digestive.
|
|
003
|
Cessation
of Cryptosporidium-associated diarrhea in an acquired immunodeficiency
syndrome patient after treatment with hyperimmune bovine colostrum.
|
|
004
|
Concentrated
bovine colostral whey proteins from Streptococcus mutans/Strep.
sobrinus immunized cows inhibit the adherence of Strep. mutans
and promote the aggregation of mutans streptococci.
|
|
005
|
Cessation
of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum.
|
|
006
|
Treatment
of Helicobacter pylori infection in infants in rural Bangladesh
with oral immunoglobulins from hyperimmune bovine colostrum.
|
|
007
|
Promoting
effect of colostrum on the phagocytic activity of bovine polymorphonuclear
leukocytes in vitro.
|
|
008
|
Successful
hyperimmune bovine colostrum treatment of Savanna monitors (Varanus
exanthematicus) infected with Cryptosporidium sp.
|
|
009
|
Characterization
of a > 900,000-M(r) Cryptosporidium parvum sporozoite glycoprotein
recognized by protective hyperimmune bovine colostral immunoglobulin
|
|
010
|
Fatty
acid composition of human colostrum and mature breast milk.
|
|
011
|
Enzymic
characteristics of fat globule membranes from bovine colostrum
and bovine milk.
|
|
012
|
The
Protective Effects of Lactoferrin Feeding against Endotoxin Lethal
Shock in Germfree Piglets .
|
|
013
|
Co-administration
of the health food supplement, bovine colostrum, reduces the acute
non-steroidal anti-inflammatory drug-induced increase in intestinal
permeability.
|
|
014
|
Gastrointestinal
Tract - Survival of rotavirus antibody activity derived from bovine
colostrum after passage through the human gastrointestinal tract.
|
|
015
|
Colostrum
and milk-derived peptide growth factors for the treatment of gastrointestinal
disorders.
|
|
016
|
Protection
by milk immunoglobulin concentrate against oral challenge with
enterotoxigenic Escherichia coli.
|
|
017
|
Bovine
colostrum immunoglobulin concentrate for cryptosporidiosis in
AIDS
|
|
018
|
Biological
activities of bovine glycomacropeptide.
|
|
019
|
Nonnutritive
Factors in Colostrum Enhance Myofibrillar Protein Synthesis in
the Newborn Pig .
|
|
020
|
In
vivo antimicrobial and antiviral activity of components in bovine
milk and colostrum involved in non-specific defence.
|
|
021
|
Suckling
Induces Rapid Intestinal Growth and Changes in Brush Border Digestive
Functions of Newborn Pigs.
|
|
022
|
Inhibition
of S-fimbria-mediated adhesion to human ileostomy glycoproteins
by a protein isolated from bovine colostrum.
|
|
023
|
Nucleosides
and nucleotides: natural bioactive substances in milk and colostrum.
|
|
024
|
Fatty
Acids.
|
|
025
|
Bone
and Joint Disease.
|
|
026
|
Gut
Health.
|
|
027
|
Rotaviral
antibodies in the treatment of acute rotaviral gastroenteritis.
|
|
028
|
Development
of the newborn GI tract and its relation to colostrum/milk intake:
a review.
|
|
029
|
Human
milk and intestinal host defense in newborns: an update.
|
|
030
|
Sialic
acid in breast milk and infant formula food.
|
|
031
|
New
Insights into the Utilization of Medium-Chain Triglycerides by
the Neonate: Observations from a Piglet Model.
|
|
032
|
A
Comparison of IgG and IgG1 Activity in an Early Milk Concentrate
from Non-Immunised Cows and a Milk from Hyperimmunised Animals.
|
|
033
|
Physical
Activity and Cancer.
|
|
034 |
Concentrated
bovine colostral whey proteins from Streptococcus mutans/Strep.
sobrinus immunized cows inhibit the adherence of Strep. mutans and
promote the aggregation of mutans streptococci. |
|
035 |
Bovine
milk antibodies for health |
|
036 |
Effect
of growth factors on cell proliferation and epithelialization in
human skin. |
|
037 |
The
effects of bovine colostrum supplementation on body composition
and exercise performance in active men and women. |
|
038 |
2000
Pre-Olympic Congress |
|
039 |
Sport
Dietry Supplements Update |
|
040 |
Growth
factors and cytokines in bone cell metabolism |
|
041 |
Increase
in Gut Permeability |
|
042 |
Bovine
colostrum ameliorates diarrhea |
|
043 |
Effects
of oral bovine colostrum supplementation |
|
044 |
Modulation
of the immune system and the response against pathogens with bovine
colostrum concentrates. |
|
045 |
IGF-I,
IgA, and IgG responses to bovine colostrum supplementation during
training. |
|
046 |
Pasteurization |
|
047 |
Glutathione
and Colostrum |
|
048 |
Effects
of orally administered bovine lactoferrin on the immune system of
healthy volunteers. |
|
049 |
Lactoferrin
Levels |
|
050 |
Bovine
lactoferrin and lactoferricin derived from milk: production and
applications. |
|
051 |
Growth
inhibitory effect of bovine lactoferrin |
|
052 |
Milk
and dairy products in cancer prevention |
|
053 |
Composition
of Colostrum and Feeding Duration |
|
054 |
The
Neonate and Colostrum |
|
055 |
The
Demographics of neo natal mortality |
|
056 |
Sports
Dietary Supplement and Colostrum |
|
057 |
Influence
of Cross-fostering on Piglet Growth and Survival
|
|
058 |
Neonatal
Mortality and Weaning Weight
|
|
059 |
Treatment
of multiple sclerosis with anti-measles cow colostrum |
|
060 |
Management
Tips To Reduce Pre-weaning Mortality |
|
061 |
Effect
of an oral bovine colostrum supplement
(intact TM ) on running performance |
|
062 |
Human
Colostrum IgA Antibodies and Enteropathogenic Escherichia coli Antigens |
|
063 |
Care
of Pigs From Farrowing to Weaning |
|
064 |
Bovine
colostrum ameliorates diarrhea |
|
065 |
Lactoperoxidase
|
|
066 |
Oligosaccharides
and glycoconjugates in bovine milk and colostrum |
|
067 |
Vivo
antimicrobial and antiviral activity |
|
068 |
Lactoferrin
and its biological functions |
|
070 |
Growth
factors and cytokines in bone cell metabolism |
|
071 |
Treatment
of multiple sclerosis with anti-measles cow colostrum |
|
072 |
Gastrointestinal
injury and colostrum |
|
073 |
Bovine
colostrum supplementation on body composition and exercise performance |
|
074 |
Increased
bacterial urease activity in faeces in juvenile chronic arthritis:
evidence of altered intestinal microflora |
|
075 |
Effect
of androgens on the brain and other organs during development and
aging. |
|
076 |
Colostrum
and milk-derived peptide growth factors for the treatment of gastrointestinal
disorders |
|
077 |
Enhancement
of Immunity in the Elderly by Dietary Supplementation with the Probiotic
Bifidobacterium lactis HN0191 |
|
078 |
Bovine
colostrum supplementation enhances physical performance on maximal
exercise tests |
|
079 |
Effects
of oral bovine colostrum supplementation on serum insulin-like growth
factor-i levels |
|
080 |
Effects
of orally administered bovine lactoferrin on the immune system of
healthy volunteers |
|
081 |
Bovine
lactoferrin and lactoferricin derived from milk: production and
applications |
|
082 |
Growth
inhibitory effect of bovine lactoferrin to Toxoplasma gondii tachyzoites
in murine macrophages |
|
083 |
Feeding
Colostrum, Its Composition and Feeding Duration Variably Modify
Proliferation and Morphology of the Intestine and Digestive Enzyme
Activities of Neonatal Calves |
|
084 |
Nonnutritive
Factors in Colostrum Enhance Myofibrillar Protein Synthesis in the
Newborn Pig
|
|
085 |
The
Protective Effects of Lactoferrin Feeding against Endotoxin Lethal
Shock in Germfree Piglets |
|
086 |
Inhibition
of S-fimbria-mediated adhesion to human ileostomy glycoproteins
by a protein isolated from bovine colostrum |
|
087 |
Bovine
colostrum immunoglobulin concentrate for cryptosporidiosis in AIDS |
|
088 |
Characterization
of a > 900,000-M(r) Cryptosporidium parvum sporozoite glycoprotein
recognized by protective hyperimmune bovine colostral immunoglobulin |
|
089 |
Essential
fatty acid composition of human colostrum triglycerides: its relationship
with adipose tissue composition |
|
090 |
Cessation
of Cryptosporidium-associated diarrhea in an acquired immunodeficiency
syndrome patient after treatment with hyperimmune bovine colostrum |
|
091 |
Protection
by milk immunoglobulin concentrate against oral challenge with enterotoxigenic
Escherichia coli
|
|
092 |
Suckling
Induces Rapid Intestinal Growth and Changes in Brush Border Digestive
Functions of Newborn Pigs |
|
093 |
Fatty
acid composition of human colostrum and mature breast milk |
|
094 |
Enzymic
characteristics of fat globule membranes from bovine colostrum and
bovine milk
|
|
095 |
Milk
and dairy products in cancer prevention: focus on bovine lactoferrin
|
|
096 |
Immune
response of pregnant heifers and cows to bovine rotavirus inoculation.
|
|
097 |
Vaccination
studies against experimental bovine Pasteurella pneumonia |
|
098 |
The
Demographics of Neonatal Mortality and the Benefits of Crossfostering |
|
099 |
Farrowing
Management and Piglet Losses |
|
100 |
Nonnutritive
Factors in Colostrum Enhance Myofibrillar Protein Synthesis in the
Newborn Pig |
|
101 |
Comparison
of the gastrointestinal growth
|
|
102 |
Colostrum
and milk-derived peptide growth factors for the treatment of gastrointestinal
disorders |
|
103 |
Vitamin
E, lipid fractions, and fatty acid composition of colostrum, transitional
milk, and mature milk: an international comparative study |
|
104 |
Effect
of maternal nutritional status on immunological substances in human
colostrum and milk
|
|
105 |
Microparticle-enhanced
nephelometric immunoassay of lysozyme in milk and other human body
fluids |
|
106 |
Effect
of extra N-terminal residues on the stability and folding of human
lysozyme expressed in Pichia pastoris
|
|
107 |
The
evolution of lysozyme and alpha-lactalbumin
|
|
108 |
Lysozyme,
lactoferrin, and secretory immunoglobulin A content in breast milk:
influence of duration of lactation, nutrition status, prolactin
status, and parity of mother |
|
109 |
Serum
lysozyme: evaluation of a nephelometric assay.
|
|
110 |
Radioimmunoassay
for urinary lysozyme in human serum from leukemic patients
|
|
111 |
Measurement
of lysozyme by an enzyme-linked immunosorbent assay |
|
112 |
Immunochemical determination
of human lysozyme by laser nephelometry |
|
113 |
Limitations
of conventional laser nephelometry for the measurement of beta 2-microglobulin,
lysozyme, alpha 1 fetoprotein and myoglobin in serum and urine
|
|
114 |
Microparticle-enhanced
nephelometric immunoassay of alpha-lactalbumin in human milk
|
|
115 |
Measurement
of beta-casein in human milk by microparticle-enhanced nephelometric
immunoassay
|
|
116 |
Microparticle-enhanced
nephelometric immunoassay (Nephelia) for immunoglobulins G, A, and
M |
|
117 |
Measurement
of lysozyme in human body fluids |
|
118 |
Viral
Load in Breast Milk Correlates with Transmission of Human Cytomegalovirus
to Preterm Neonates, but Lactoferrin Concentrations Do Not
|
|
119 |
Antiviral
effects of plasma and milk proteins |
|
120 |
Synergistic
Fungistatic Effects of Lactoferrin in Combination with Antifungal
Drugs against Clinical Candida Isolates
|
|
121 |
Lactoferrin:
a general review |
|
122 |
Lactoferrin: Molecular Structure
and Biological Function |
|
123 |
In
vitro antiviral activity of lactoferrin and ribavirin upon hantavirus
|
